Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

735
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
735

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in Cell Therapy for Neural Repair.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Dynamic transcriptomic remodeling in grafted human neural progenitor cells uncovers mechanisms for vision preservation in a rat model of retinitis pigmentosa.

Nature communications·2026
Same author

Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls.

Nature communications·2024
Same author

Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells.

Lab on a chip·2024
Same author

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.

Neurology and therapy·2023
Same author

Survival of the fittest glia.

Nature biotechnology·2023
Same journal

Why high scores do not mean application readiness for health AI.

Nature medicine·2026
Same journal

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Nature medicine·2026
Same journal

Biological aging might help to explain the rising risk of early-onset cancer.

Nature medicine·2026
Same journal

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

Nature medicine·2026
Same journal

A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.

Nature medicine·2026
Same journal

Blood-based circular RNAs for early diagnosis of Alzheimer's disease.

Nature medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2025

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.8K

Cell therapy for neurological disorders.

Soshana P Svendsen1, Clive N Svendsen2

  • 1Cedars-Sinai Board of Governors Regenerative Medicine Institute, Los Angeles, CA, USA.

Nature Medicine
|October 15, 2024
PubMed
Summary
This summary is machine-generated.

Cell therapies offer revolutionary treatments for neurological disorders by replacing damaged tissue. Advances in stem cell technology and gene editing overcome sourcing challenges, paving the way for innovative clinical applications.

More Related Videos

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.7K
GM-Free Generation of Blood-Derived Neuronal Cells
08:11

GM-Free Generation of Blood-Derived Neuronal Cells

Published on: February 13, 2021

2.9K

Related Experiment Videos

Last Updated: Jun 10, 2025

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.8K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.7K
GM-Free Generation of Blood-Derived Neuronal Cells
08:11

GM-Free Generation of Blood-Derived Neuronal Cells

Published on: February 13, 2021

2.9K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Biotechnology

Background:

  • Cell therapies present unique challenges and opportunities for treating neurological disorders.
  • Historically, cell sourcing relied on fetal brain tissue, limiting scalability and ethical considerations.
  • Pluripotent stem cell technology has enabled large-scale generation of diverse neural cell types.

Purpose of the Study:

  • To critically evaluate the current state of clinical trials for cell therapies in neurological disorders.
  • To discuss how evolving stem cell technology and innovation can overcome existing challenges.
  • To highlight the potential of cell therapies to revolutionize treatment for debilitating neurological conditions.

Main Methods:

  • Review of current clinical trial data for cell-based neurological therapies.
  • Analysis of advancements in pluripotent stem cell technology for neural cell generation.
  • Examination of gene editing techniques for enhanced cell therapy efficacy and immune evasion.

Main Results:

  • Pluripotent stem cell technology has largely resolved historical cell sourcing limitations.
  • Gene editing offers potential for improved cell performance and reduced immunogenicity.
  • The field is rapidly advancing, with numerous innovative approaches entering clinical trials.

Conclusions:

  • Cell therapies hold immense promise for revolutionizing the treatment of neurological disorders.
  • Ongoing technological innovations in stem cell biology and gene editing are crucial for clinical success.
  • Addressing challenges in clinical translation is key to realizing the full potential of these therapies.